Tech is the solution to tackling talent shortages: here's why

2 February 2017
jim-sykes-large

In an expert view piece, Jim Sykes, sector managing director for pharmaceutical and life sciences at global talent acquisition and management firm, Alexander Mann Solutions, considers current risks of losing skilled personnel and how these can be addressed.

Suffice it to say, 2016 was a year of incredible political, economic and environmental change. It is clear that there are massive shifts in power occurring around the globe, and not one industry will be spared the impact of these potentially seismic shifts.

For the pharmaceutical industry in the UK, many historical struggles look set to worsen. Ongoing cuts in government spending, patent cliffs, and shifts in business focus between therapeutic areas are all threatening the stability of the sector, but Brexit could exacerbate this.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical